Science closing in on mystery of age-related memory loss

May 06, 2010

The world's scientific community may be one step closer to understanding age-related memory loss, and to developing a drug that might help boost memory. In an editorial published May 7 in Science, J. David Sweatt, Ph.D., chair of the University of Alabama at Birmingham (UAB) Department of Neurobiology, says that drugs known as histone deacetylase inhibitors are showing great promise in stopping memory loss - and even in boosting the formation of memory in animal models.

Sweatt's editorial was published in conjunction with findings published in Science from researchers led by Shahaf Peleg at the European Neuroscience Institute at University Goettingen in Germany. The European researchers' findings supplement and support work done previously in Sweatt's laboratory.

"It's a real proof of concept," said Sweatt. "We've been studying histone deacetylase inhibitors for some 10 years. Studies in our lab and elsewhere strongly suggested that these drugs could potentially reverse aging-associated memory dysfunction.

"The new results from Peleg's group provide important proof-of-principal that this might be a viable approach to therapeutic interventions in aging."

Sweatt, director of the Evelyn F. McKnight Brain Institute at UAB, cautions that the findings have so far only been observed in mouse models. He says further research is warranted to see if the findings translate to in humans.

He is especially encouraged because histone deacetylase inhibitors seem to be beneficial in both normal age-related , as evidenced by the Peleg team's findings, and in a mouse model of Alzheimer's disease, as reported by Sweatt's laboratory earlier this year in a different paper in Neuropsychopharmacology.

"These studies will hopefully lead to more effective prevention strategies to improve quality of life in the aged, as well as contribute to a better understanding of memory," Sweatt said.

Explore further: New ALS associated gene identified using innovative strategy

Related Stories

Future therapies for stroke may block cell death

Jun 14, 2007

A new therapy to re-activate silenced genes in patients who suffer from neurodegenerative diseases or stroke is being developed by researchers at the University of Illinois at Chicago and Cornell University.

Cancer drug enhances long-term memory

Jun 05, 2007

A drug used to treat cancer has been shown to enhance long-term memory and strengthen neural connections in the brain, according to a new study by UC Irvine scientists.

Scientists ID gene key to Alzheimer's-like reversal

May 06, 2009

(PhysOrg.com) -- A team led by researchers at MIT's Picower Institute for Learning and Memory has now pinpointed the exact gene responsible for a 2007 breakthrough in which mice with symptoms of Alzheimer's disease regained ...

Recommended for you

New ALS associated gene identified using innovative strategy

1 hour ago

Using an innovative exome sequencing strategy, a team of international scientists led by John Landers, PhD, at the University of Massachusetts Medical School has shown that TUBA4A, the gene encoding the Tubulin Alpha 4A protein, ...

Can bariatric surgery lead to severe headache?

1 hour ago

Bariatric surgery may be a risk factor for a condition that causes severe headaches, according to a study published in the October 22, 2014, online issue of Neurology, the medical journal of the American Academy of Neurol ...

Bipolar disorder discovery at the nano level

2 hours ago

A nano-sized discovery by Northwestern Medicine scientists helps explain how bipolar disorder affects the brain and could one day lead to new drug therapies to treat the mental illness.

Brain simulation raises questions

5 hours ago

What does it mean to simulate the human brain? Why is it important to do so? And is it even possible to simulate the brain separately from the body it exists in? These questions are discussed in a new paper ...

Human skin cells reprogrammed directly into brain cells

5 hours ago

Scientists have described a way to convert human skin cells directly into a specific type of brain cell affected by Huntington's disease, an ultimately fatal neurodegenerative disorder. Unlike other techniques ...

User comments : 0